Alterity Therapeutics Limited
ATHE
$4.32
-$0.29-6.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.89M | -10.46M | -13.05M | -12.83M | -12.56M |
| Total Depreciation and Amortization | 90.60K | 93.40K | 96.50K | 96.90K | 96.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 762.30K | 728.10K | 696.50K | 555.00K | 407.10K |
| Change in Net Operating Assets | -443.00K | 469.90K | 1.39M | 2.57M | 3.78M |
| Cash from Operations | -7.48M | -9.17M | -10.86M | -9.60M | -8.28M |
| Capital Expenditure | -- | 0.00 | 0.00 | -1.90K | -3.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.75M | -2.35M | -- | -- | -- |
| Cash from Investing | -4.75M | -2.35M | 0.00 | -1.90K | -3.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -127.00K | -75.40K | -23.80K | -17.10K | -10.40K |
| Issuance of Common Stock | 42.57M | 25.87M | 9.17M | 9.66M | 10.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.77M | -1.73M | -686.60K | -802.30K | -918.00K |
| Cash from Financing | 25.16M | 15.24M | 5.57M | 5.82M | 6.06M |
| Foreign Exchange rate Adjustments | -126.90K | 10.30K | 146.30K | 158.70K | 171.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.79M | 3.73M | -5.14M | -3.63M | -2.05M |